59025 billing guidelines
Townsend et al (2019) noted that primary studies and systematic reviews provided estimates of varying accuracy for different factors in the prediction of PE. Hypertens Pregnancy. 2013;32(9):1593-1600. How Will The End Of The PHE Affect Telehealth And Digital Health? 25. The review found that uterine artery Doppler screening of high-risk women (e.g., history of chronic hypertension or preeclampsia, prior fetal growth restriction, or stillbirth) with singleton gestations appears to identify those at substantially increased risk for adverse pregnancy outcomes (Scicioneand Hayes, 2009). Medline, Embase and the Cochrane Library including DARE (Database of Abstracts of Reviews of Effects) databases, from database inception to March 2017, and bibliographies of relevant articles were searched, without language restrictions, for systematic reviews and meta-analyses on the prediction of PE. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. Br J Obstet Gynaecol. These researchers stated that prospective, well-designed studies of predictive markers, preferably randomized intervention studies, and combined through individual-patient data meta-analysis are needed to develop and validate new prediction models to facilitate the prediction of PE and minimize further research waste in this field. von See et al (2016) noted that the angiogenic factors sFlt-1 and PlGF are significantly altered in PE with elevated sFlt-1 levels and low PlGF in the continuation of pregnancies. In a Cochrane review, Alfirevic et al (2015) examined the effects of routine fetal and umbilical Doppler ultrasound on obstetric practice and pregnancy outcome in unselected and low-risk pregnancies. For a fixed false-positive rate of 10 %, ADAM12, PAPP-A, and Ut-A Doppler parameters in combination with maternal characteristics identified 50 %, 48 %, and 52 % of patients who developed PE, respectively. To separately bill this service with 59025 ( Fetal nonstress test ), your ob-gyn must document a clear indication for doing the NST (for instance, to measure fetal wellbeing).You must have a report with the findings and a recommendation for further testing or treatment.